HHS Offers More Money for Fighting Zika in U.S. Territories

Being infected with the Zika virus during pregnancy can cause microcephaly and other severe brain defects. As of Oct. 26, 2016, more than 32,000 laboratory-confirmed cases of Zika have been reported to the Centers for Disease Control and Prevention from U.S. states (4,091 cases) and territories (28,723 cases).

The Health Resources and Services Administration, an HHS agency, announced Oct. 28 it has made $39 million available for health centers in Puerto Rico, American Samoa, and the U.S. Virgin Islands so they can offer more preventive and primary health care services to meet immediate and anticipated Zika-related health care needs and allow health centers to expand services in response to other primary health needs.

Being infected with the Zika virus during pregnancy can cause microcephaly and other severe brain defects. As of Oct. 26, 2016, more than 32,000 laboratory-confirmed cases of Zika have been reported to the Centers for Disease Control and Prevention from U.S. states (4,091 cases) and territories (28,723 cases), according to the HHS announcement.

"As Zika transmission continues, additional resources are necessary to expand health centers’ response to current and evolving Zika-related needs," said HRSA Acting Administrator Jim Macrae. "These supplemental Zika funds will enable health centers to provide additional high-quality services to underserved populations."

The funding will specifically be made available for use over a three-year period to eligible Health Center Program-funded health centers in these territories. For more information on U.S. efforts to combat the virus, visit https://www.cdc.gov/zika/. To learn more about HRSA's Health Center Program, visit http://bphc.hrsa.gov/about/index.html.

Product Showcase

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" 3

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. 3

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! 3

Featured